7Baggers
 Persistent corneal epithelial defects (PCEDs) Pipeline  openPR.com Mon, 28 Apr 2025 05:35:00 GMT
 Neurotrophic Keratitis Market to Expand Significantly by 2034,  openPR.com Thu, 17 Apr 2025 07:00:00 GMT
 oyster point pharma inc to host earnings call  ACCESS Newswire Thu, 06 Mar 2025 04:00:14 GMT
 dry eye syndrome treatment (evaporative, aqueous deficient)  GlobeNewswire Wed, 20 Nov 2024 11:20:08 GMT
 dry eye syndrome treatment (evaporative, aqueous deficient)  GlobeNewswire Tue, 19 Nov 2024 16:25:12 GMT
 neurotrophic keratitis treatment market 2034: clinical  openPR Tue, 08 Oct 2024 07:00:00 GMT
 opthea limited announces key executive leadership changes and senior hires  Ophthalmology Times Sun, 22 Sep 2024 07:00:00 GMT
 voices in pharmacy: august 2024 expert interviews  Drug Topics Mon, 26 Aug 2024 07:00:00 GMT
 David Benadon| 塩野義製薬  Shionogi Inc. Sat, 29 Jun 2024 18:08:50 GMT
 we're not very worried about oyster point pharma's (nasdaq:oyst) cash burn rate  Yahoo News Australia Sat, 29 Jun 2024 03:51:15 GMT
 do institutions own oyster point pharma, inc. (nasdaq:oyst) shares?  Yahoo News UK Sun, 09 Jun 2024 09:04:54 GMT
 tectonic therapeutic appoints daniel lochner as cfo  citybiz Mon, 03 Jun 2024 07:00:00 GMT
 cytophage strengthens board of directors  TheNewswire.ca Mon, 27 May 2024 07:00:00 GMT
 ers international congress 2016 - us fda, oyster point pharma  The Pharma Letter Thu, 16 May 2024 08:03:09 GMT
 aacr annual meeting 2017 - varenicline  The Pharma Letter Fri, 10 May 2024 15:02:36 GMT
 aacr annual meeting 2018 - oyster point pharma, varenicline  The Pharma Letter Mon, 06 May 2024 08:24:37 GMT
 how oyster point (oyst) stock stands out in a strong industry  Yahoo New Zealand News Thu, 02 May 2024 17:00:40 GMT
 fda approves first nasal spray for chronic dry eyes  McKnight's Long-Term Care News Sun, 21 Apr 2024 14:10:38 GMT
 are insiders buying oyster point pharma, inc. (nasdaq:oyst) stock?  Yahoo Canada Shine On Fri, 19 Apr 2024 14:11:13 GMT
 are insiders buying oyster point pharma, inc. (nasdaq:oyst) stock?  Yahoo Canada Shine On Wed, 17 Apr 2024 21:51:00 GMT
 moving beyond the drop: ceo provides updates on oyster point's pipeline  Ophthalmology Times Wed, 21 Feb 2024 19:07:30 GMT
 gene therapies in ophthalmology clinical trial pipeline  GlobeNewswire Mon, 19 Feb 2024 08:00:00 GMT
 kilroy's mega project at oyster point is facing a 6 month delay. here's why  The Business Journals Thu, 08 Feb 2024 08:00:00 GMT
 moving beyond the drop: ceo provides updates on oyster point's pipeline  Ophthalmology Times Sun, 04 Feb 2024 00:56:15 GMT
 moving beyond the drop: ceo provides updates on oyster point's pipeline  Ophthalmology Times Fri, 19 Jan 2024 08:00:00 GMT
 bayer backs chinese biotech with novel heart disease pipeline  The Pharma Letter Thu, 11 Jan 2024 08:00:00 GMT
 transmucosal drug delivery pipeline report 2023 - stages of ...  Business Wire Fri, 24 Nov 2023 15:22:00 GMT
 when managing cases of dry eye, expect the unexpected  Ophthalmology Times Fri, 24 Nov 2023 11:03:45 GMT
 mindfulness-based cognitive therapy shows promise in alleviating ...  Ophthalmology Times Fri, 24 Nov 2023 11:01:53 GMT
 załącznik do naszego komunikatu prasowego #eulife22 – krótkie ...  European Commission Thu, 23 Nov 2023 08:00:00 GMT
 annex to our #eulife22 press release - project short summaries  European Commission Tue, 14 Nov 2023 08:00:00 GMT
 achieving net-zero in the dry eye disease care pathway | eye  Nature.com Mon, 13 Nov 2023 08:00:00 GMT
 a review of the first anti-evaporative prescription treatment for dry ...  AJMC.com Managed Markets Network Fri, 03 Nov 2023 07:00:00 GMT
 world on brink of environmental tipping points, un says  Reuters Wed, 25 Oct 2023 07:00:00 GMT
 pearls for integrating dry eye disease management into your practice  Ophthalmology Times Fri, 20 Oct 2023 07:00:00 GMT
 access is the issue  Healio Fri, 20 Oct 2023 07:00:00 GMT
 aaopt 2023: what's new in dry eye?  Optometry Times Thu, 12 Oct 2023 07:00:00 GMT
 panel: explain risks of untreated myopia progression  Healio Tue, 10 Oct 2023 07:00:00 GMT
 okyo pharma files ind with us fda for the development of ok-101 ...  Ophthalmology Times Mon, 09 Oct 2023 07:00:00 GMT
 viatris to haul in $3.37b with 3 business divestures  FiercePharma Mon, 02 Oct 2023 07:00:00 GMT
 an aye for the eyes: ocuphire and viatris get an approval  BioWorld Online Wed, 27 Sep 2023 07:00:00 GMT
 dry eye treatment with cryopreserved amniotic membrane | opth  Dove Medical Press Tue, 12 Sep 2023 07:00:00 GMT
 landscape architect's goal of nature-based infrastructure  PBS NewsHour Tue, 29 Aug 2023 07:00:00 GMT
 sjögren syndrome: a three-part ded treatment plan and insights ...  Optometry Times Wed, 23 Aug 2023 07:00:00 GMT
 where will viatris be in 5 years?  The Motley Fool Fri, 18 Aug 2023 07:00:00 GMT
 viatris says its divestures, return to growth strategy on track  FiercePharma Wed, 09 Aug 2023 07:00:00 GMT
 okyo pharma announces plans to initiate trial of ok-101 in ...  Ophthalmology Times Tue, 01 Aug 2023 07:00:00 GMT
 he's shucking oysters at dive bars, and we tested the quickest way ...  The Philadelphia Inquirer Thu, 20 Jul 2023 07:00:00 GMT
 pearl & mary is carrying on philly's oyster bar tradition. the menu is ...  The Philadelphia Inquirer Mon, 17 Jul 2023 07:00:00 GMT
 researchers set sights on probiotic for dry eye disease  FierceBiotech Tue, 20 Jun 2023 07:00:00 GMT
 aldeyra's dry eye disease drug scores phase 3 conjunctivitis win  FierceBiotech Thu, 15 Jun 2023 07:00:00 GMT
 paola-1 and prima study designs. *patients with other epithelial...  ResearchGate Tue, 13 Jun 2023 05:32:34 GMT
 a (sadly) unavoidable review of otc eye drops  Healio Tue, 30 May 2023 07:00:00 GMT
 oyster point pharma inc - company profile  GlobalData Tue, 23 May 2023 20:21:00 GMT
 2023 sales forecast reaffirmed by viatris on strong demand for newer drugs  BW Healthcare World Wed, 10 May 2023 07:00:00 GMT
 viatris reaffirms 2023 sales forecast on strong demand for newer drugs  ETHealthWorld Tue, 09 May 2023 07:00:00 GMT
 aav vectors in gene therapy pipeline experiences momentum:  GlobeNewswire Thu, 27 Apr 2023 07:00:00 GMT
 fitch affirms idr of viatris at 'bbb'; outlook stable  Fitch Ratings Tue, 25 Apr 2023 07:00:00 GMT
 6 of the top biotech companies to know about in south san francisco  Labiotech.eu Thu, 20 Apr 2023 07:00:00 GMT
 dry eye syndrome market size, share | cagr of 5.9%  Market.us Mon, 17 Apr 2023 09:26:16 GMT
 here's how you can collect $100 in dividends every month  The Motley Fool Wed, 05 Apr 2023 07:00:00 GMT
 adt: 3 stocks to buy with less than $10  StockNews.com Mon, 20 Mar 2023 16:51:26 GMT
 chutes & ladders—biogen names stelios papadopoulos' successor  Fierce Biotech Fri, 10 Mar 2023 08:00:00 GMT
 biogen taps new board chair—chutes & ladders  FierceBiotech Fri, 10 Mar 2023 08:00:00 GMT
 ian nussbaum  ILW.com Wed, 08 Mar 2023 14:53:01 GMT
 novabay pharmaceuticals inc. announces the launch of avenova ...  Ophthalmology Times Wed, 08 Mar 2023 08:00:00 GMT
 billy dunn departs fda—chutes & ladders  FierceBiotech Fri, 03 Mar 2023 08:00:00 GMT
 biocon raises rs 1067 crore from kotak to fund biosimilars deal  Medical Dialogues Thu, 23 Feb 2023 08:00:00 GMT
 becoming a one-stop shop for respiratory illness testing  Drug Topics Tue, 21 Feb 2023 08:00:00 GMT
 nutritional supplements can improve acceptance, durability of in ...  Ophthalmology Times Fri, 17 Feb 2023 08:00:00 GMT
 viatris aims to be global eye care leader  FiercePharma Thu, 12 Jan 2023 08:00:00 GMT
 viatris forms eye care unit from acquisitions  CHEManager Tue, 10 Jan 2023 08:00:00 GMT
 cooley continues climb in us and global m&a and private equity ...  Cooley LLC Fri, 06 Jan 2023 08:00:00 GMT
 Viatris launches eye-care division  Pennsylvania Business Report - Wed, 04 Jan 2023 16:34:25 GMT
 why these 7 healthcare stocks could soar in 2023  InvestorPlace Mon, 02 Jan 2023 08:00:00 GMT
 2022 turns out to be another unspectacular year for pharma and ...  The Pharma Letter Mon, 02 Jan 2023 08:00:00 GMT
 sahara study looks at dry eye treatments covered by insurers  Optometry Times Thu, 29 Dec 2022 08:00:00 GMT
 Pipeline update from Oyster Point Pharma  Optometry Times Tue, 20 Dec 2022 08:00:00 GMT
 viatris to commercialize calliditas’ nefecon in japan  The Pharma Letter Tue, 13 Dec 2022 08:00:00 GMT
 biocon biologics completes $3 billion acquisition of viatris’ biosimilars  Managed Healthcare Executive Mon, 12 Dec 2022 08:00:00 GMT
 blog: viatris, a new industry player, buys oyster point  Healio Fri, 02 Dec 2022 08:00:00 GMT
 better dividend stock: abbvie or viatris?  The Motley Fool Sat, 26 Nov 2022 08:00:00 GMT
 viatris and oyster point – mylan all over again? (nasdaq:oyst)  Seeking Alpha Thu, 17 Nov 2022 08:00:00 GMT
 aacr annual meeting 2018 - famy life sciences, oyster point pharma  The Pharma Letter Sun, 13 Nov 2022 08:00:00 GMT
 White & Case Advises Famy Life Sciences on Its Acquisition by Viatris Inc.  White & Case LLP Thu, 10 Nov 2022 08:00:00 GMT
 here’s why viatris (nasdaq:vtrs) shares soared 13% recently  TipRanks Tue, 08 Nov 2022 16:56:58 GMT
 Viatris agrees to acquire Oyster Point and Famy Life Sciences  Pharmaceutical Technology Tue, 08 Nov 2022 08:00:00 GMT
 Centerview grows role as go-to adviser for biopharma dealmaking  BioPharma Dive Tue, 08 Nov 2022 08:00:00 GMT
 Viatris to create ophthalmology franchise via two M&A deals  The Pharma Letter Tue, 08 Nov 2022 08:00:00 GMT
 viatris’ far-sighted binocular move brings aboard oyster, famy pipelines  BioWorld MedTech Tue, 08 Nov 2022 08:00:00 GMT
 oyster point pharma to be acquired by viatris  Vision Monday Tue, 08 Nov 2022 08:00:00 GMT
 2 eye drug developers to be acquired in deals worth $700m+  InvisionMag Tue, 08 Nov 2022 08:00:00 GMT
 healthcare firm offers us$295m for ophthalmology co. trending company  Streetwise Reports Tue, 08 Nov 2022 08:00:00 GMT
 makeover sees viatris move further away from generics  Evaluate Pharma Tue, 08 Nov 2022 08:00:00 GMT
 oyster point pharma skyrockets on viatris deal - tipranks.com  TipRanks Mon, 07 Nov 2022 14:35:34 GMT

Oyster Point Pharma, Inc
(NASDAQ:OYST) 

OYST stock logo

Oyster Point Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical therapies to treat ocular surface diseases in the United States. The company's lead product candidate is OC-01, a nicotinic acetylcholine receptor ago...

Founded: 2015
IPO Price: $16 (Oct 31, 2019)
Full Time Employees: 62 (May 2021)
CEO: Jeffrey A. Nau  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends